Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Foundation Medicine Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Foundation Medicine Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Foundation Medicine Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Foundation Medicine Inc, Medical Equipment, Deals By Market, 2011 to YTD 2017 9
Foundation Medicine Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Foundation Medicine Inc, Medical Equipment, Deal Details 12
Venture Financing 12
Cota Raises Funds through Venture Financing 12
Foundation Medicine Raises US$56 Million In Series B Financing 13
Foundation Medicine Secures Additional US$8.5 Million In Series A Venture Financing 15
Foundation Medicine Raises US$10 Million In Venture Financing 17
Partnerships 18
Foundation Medicine Enters into Licensing Agreement with WuXi PharmaTech 18
Foundation Medicine Enters into Agreement with AstraZeneca 19
Foundation Medicine Enters into Agreement with Mirati Therapeutics 20
IMS Health Enters into Agreement with Foundation Medicine 21
Foundation Medicine Enters into Co-Development Agreement with Flatiron Health 22
Foundation Medicine Extends Co-Development Agreement With Clovis Oncology 23
Foundation Medicine Enters Into Co-Development Agreement With Memorial Sloan-Kettering Cancer Center 24
Foundation Medicine Enters Into Agreement With Agios Pharma To Develop Cancer Diagnostics 25
Foundation Medicine Enters Into Agreement With Eisai For Genomic Profiling And Diagnostic Discovery 26
Foundation Medicine Enters Into Co-Development Agreement With Clovis Oncology 27
Foundation Medicine Extends Co-Development Agreement With Novartis 28
Foundation Medicine Enters Into Co-Development Agreement With Sanofi For Genetic Biomarkers And Potential Diagnostics 29
Foundation Medicine Enters Into An Agreement With Novartis 30
Foundation Medicine Expands Co-Development Agreement With Novartis 31
Equity Offering 32
Foundation Medicine Raises USD250 Million in Private Placement of Shares 32
Foundation Medicine Withdraws Public Offering Of Shares For Up To US$150 Million 33
Foundation Medicine Completes IPO Of Shares For US$122 Million 34
Foundation Medicine Inc – Key Competitors 35
Foundation Medicine Inc – Key Employees 36
Foundation Medicine Inc – Locations And Subsidiaries 37
Head Office 37
Other Locations & Subsidiaries 37
Recent Developments 38
Strategy And Business Planning 38
Jun 08, 2017: ASCO and Foundation Medicine Announce Collaboration to Help Research Sites Identify Potential Participants for the Targeted Agent and Profiling Utilization Study 38
Financial Announcements 39
Nov 01, 2017: Foundation Medicine Announces 2017 Third Quarter Results and Recent Highlights 39
Aug 01, 2017: Foundation Medicine Announces 2017 Second Quarter Results and Recent Highlights 40
May 09, 2017: Foundation Medicine Announces 2017 First Quarter Results and Recent Highlights 42
Feb 22, 2017: Foundation Medicine Announces 2016 Fourth Quarter and Year-End Results, Recent Highlights and 2017 Outlook 44
Jan 09, 2017: Foundation Medicine Reports Preliminary 2016 Results 45
Nov 02, 2016: Foundation Medicine Announces 2016 Third Quarter Results and Recent Highlights 47
Aug 02, 2016: Foundation Medicine Announces 2016 Second Quarter Results and Recent Highlights 49
May 03, 2016: Foundation Medicine Announces 2016 First Quarter Results and Recent Highlights 51
Feb 23, 2016: Foundation Medicine Announces 2015 Fourth Quarter and Year-End Results, Recent Highlights and 2016 Outlook 52
Corporate Communications 53
Oct 10, 2017: Foundation Medicine Appoints Tom Civik as Chief Commercial Officer 53
Jan 06, 2017: Foundation Medicine Announces Executive Leadership Transition 54
Oct 27, 2016: Foundation Medicine Adds Life Sciences Leader Michael R. Dougherty to its Board of Directors 55
Legal and Regulatory 56
Nov 07, 2017: Caris Life Sciences Files Patent Infringement Suit against Foundation Medicine 56
Government and Public Interest 57
Aug 15, 2017: Cancer Treatment Centers Of America And Foundation Medicine Join Forces to Advance Precision Cancer Treatment 57
Product News 58
May 18, 2017: Foundation Medicine and Its Collaborators to Present New Data at ASCO 2017 Supporting the Integration of Comprehensive Genomic Profiling in Personalized Clinical Care in Oncology 58
Aug 22, 2016: Foundation Medicine Adds New Immunotherapy Features to Its Market-Leading Products 60
May 17, 2016: Foundation Medicine Receives Patent Covering Fundamental Methods in Comprehensive Genomic Analysis in Cancer 61
03/23/2016: Foundation Medicine and Memorial Sloan Kettering Publish Validation Data for FoundationOne Heme in the Journal Blood 62
03/17/2016: Foundation Medicine Announces Presentations at the AACR Annual Meeting 2016 64
03/16/2016: Foundation Medicine Presents New Data at the 2016 USCAP Annual Meeting Underscoring Importance of Comprehensive Genomic Profiling in Cancer Care 66
Other Significant Developments 68
Feb 25, 2016: Foundation Medicine Announces First-Ever Public Release of Broad Pediatric Data From FoundationCORE to Accelerate the Development of Precision Medicine Strategies for Pediatric Cancers 68
Appendix 69
Methodology 69
About GlobalData 69
Contact Us 69
Disclaimer 69
Foundation Medicine Inc, Medical Equipment, Key Facts, 2016 2
Foundation Medicine Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 2
Foundation Medicine Inc, Medical Equipment, Deals By Year, 2011 to YTD 2017 6
Foundation Medicine Inc, Medical Equipment Deals By Type, 2011 to YTD 2017 7
Foundation Medicine Inc, Medical Equipment, Deals By Region, 2011 to YTD 2017 8
Foundation Medicine Inc, Deals By Market, 2011 to YTD 2017 9
Foundation Medicine Inc, Medical Equipment, Deals Summary, 2011 to YTD 2017 10
Cota Raises Funds through Venture Financing 12
Foundation Medicine Raises US$56 Million In Series B Financing 13
Foundation Medicine Secures Additional US$8.5 Million In Series A Venture Financing 15
Foundation Medicine Raises US$10 Million In Venture Financing 17
Foundation Medicine Enters into Licensing Agreement with WuXi PharmaTech 18
Foundation Medicine Enters into Agreement with AstraZeneca 19
Foundation Medicine Enters into Agreement with Mirati Therapeutics 20
IMS Health Enters into Agreement with Foundation Medicine 21
Foundation Medicine Enters into Co-Development Agreement with Flatiron Health 22
Foundation Medicine Extends Co-Development Agreement With Clovis Oncology 23
Foundation Medicine Enters Into Co-Development Agreement With Memorial Sloan-Kettering Cancer Center 24
Foundation Medicine Enters Into Agreement With Agios Pharma To Develop Cancer Diagnostics 25
Foundation Medicine Enters Into Agreement With Eisai For Genomic Profiling And Diagnostic Discovery 26
Foundation Medicine Enters Into Co-Development Agreement With Clovis Oncology 27
Foundation Medicine Extends Co-Development Agreement With Novartis 28
Foundation Medicine Enters Into Co-Development Agreement With Sanofi For Genetic Biomarkers And Potential Diagnostics 29
Foundation Medicine Enters Into An Agreement With Novartis 30
Foundation Medicine Expands Co-Development Agreement With Novartis 31
Foundation Medicine Raises USD250 Million in Private Placement of Shares 32
Foundation Medicine Withdraws Public Offering Of Shares For Up To US$150 Million 33
Foundation Medicine Completes IPO Of Shares For US$122 Million 34
Foundation Medicine Inc, Key Competitors 35
Foundation Medicine Inc, Key Employees 36
Foundation Medicine Inc, Other Locations 37